ClinicalTrials.Veeva

Menu

Prevalence of Clopidogrel (Plavix) Resistance in Hemodialysis Patients

Northwell Health logo

Northwell Health

Status

Completed

Conditions

Cardiovascular Disease

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The investigators are trying to find out if Clopidogrel (Plavix) is as effective in hemodialysis patients as in patients not hemodialysed.

Full description

Cardiovascular disease is very frequent in hemodialysis patients. Lot of hemodialysis patients are on Clopidogrel (plavix). Their is some evidence that clopidogrel is not effective in hemodialysis as it is effective in patient without kidney problem.

VerifyNow plavix is a machine that measure the ability of the blood to clot after giving plavix.

We will collect blood from hemodialysis patients on plavix and check the ability of their blood to clot and thus indirectly measuring the efficacy of Plavix.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients on hemodialysis taking Plavix

Exclusion criteria

  • known to have bleeding disorder
  • Severely anemic with hemoglobin level (Hb) < 10g/dl
  • Low Platelets < 10000

Trial design

100 participants in 1 patient group

patient on hemodialysis taking plavix
Description:
patient on hemodialysis taking plavix

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems